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Introduction
Incontinentia pigmenti (IP) is a rare X-linked domi-
nantly inherited genodermatosis that is usually lethal
during the prenatal stage for males. In affected females,
it causes abnormalities in skin, nails, teeth, hair, eyes
and the central nervous system.1 The pathogenesis of
IP has been indentified in mutations of the NEMO/
IKKγ (nuclear factor κB essential modulator/inhibitor
κB kinase, γ subunit) gene.2
Behçet’s disease is a systemic vasculitis with unknown
etiology, characterized by relapsing episodes of oral
ulcers, genital ulcers, skin lesions, and ocular lesions.
It is believed that an autoimmune process and a human
leukocyte antigen (HLA)-B51 are the most strongly
associated risk factors.3
There have been 2 case reports of IP concurrent
with Behçet’s disease.4,5 However, these reports were
of sporadic cases, and there was no familial concur-
rence of the 2 diseases. To the best of our knowledge,
our report is the first to delineate the concurrence of
these 2 diseases in a family. We describe the clinical fea-
tures, immunological status, and treatment modalities.
In addition, the relationship between IP and Behçet’s
disease is discussed.
Case Report
A 10-year-old girl presented with recurrent painful
oral ulcers. She had swirled and linear hyperpig-
mented lesions over her entire body (Figure 1) that
first appeared in infancy, and IP had been previously
diagnosed according to the criteria suggested by
Landy and Donnai in 1993.6 The patient’s mother
was also a case of IP—typical skin manifestations,
proved by skin biopsy, and anomalous dentition.
Since the age of 7 years, the patient had suffered from
recurrent oral ulcers with dysphagia followed, at the
age of 8 years, by recurrent urethral ulcers. The ulcers
were resistant to oral antibiotics. She was admitted to
our hospital at the age of 10 years after experiencing
oral ulcers, difficulty swallowing and intermittent
fever for several days. She had no history of eye, skele-
ton, or intelligence impairment. A review of her med-
ical history revealed 4 episodes of pneumonia since
the age of 4 months and 1 episode of cellulitis over
her left cheek at the age of 10 years. No specific
pathogens were identified in these episodes. The 
family history (Figure 2) revealed that her sister and
mother had been diagnosed with IP during child-
hood. Other family members denied any history of
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IP, Behçet’s disease, autoimmune disease or immun-
odeficiency. The patient’s mother was also diagnosed
with Behçet’s disease with the initial presentations of
recurrent oral and genital ulcers in her teenage years.
At the age of 45 years, the patient’s mother suffered
from colon ulcerations complicated with massive
bleeding and underwent subtotal colectomy. In addi-
tion, the patient’s nephew, who had suffered from
recurrent bacteremia from the age of 1 month, was
diagnosed with immunodeficiency characterized by
hypogammaglobulinemia. He is currently 1 year old
and is receiving prophylactic antibiotics and monthly
intravenous immunoglobulin treatment.
Physical examination of our patient showed stable
vital signs and clear consciousness. Her body weight
and body height were both below the 3rd percentile.
Multiple small ulcers over the posterior pharyngeal wall
and 1 deep ulcer of 2 cm in size over the oropharynx
were observed. Scar formation over a previous bacille
Calmette-Guérin vaccination site was present. Some
scar formation over the genital organs without obvi-
ous active genital ulcers was observed at this time.
There were brownish hyperpigmented lesions in a lin-
ear and swirled pattern on the patient’s trunk and
extremities. Some acne-like papules over her face were
also noted. Ophthalmologic and neurological exami-
nations showed no abnormalities. A dental X-ray
showed congenital missing teeth: 1 lower lateral and
2 upper lateral incisors. The skin pathergy reaction
was negative.
The patient had leukocytosis (white blood cell count,
18,700/mm3; neutrophils/lymphocytes, 82.5%/
12.7%), slightly hypochromic microcytic anemia, and
thrombocytosis (610 × 103/mm3). The results of uri-
nalysis showed that microscopic hematuria (5–10 red
blood cells/high-powered field) and blood chemistry
were within normal limits. Immunological study showed
high serum C-reactive protein (CRP, 13 mg/dL) and
erythrocyte sedimentation rate (ESR, 114 mm/hr).
Levels of serum immunoglobulin (Ig)G (2,350mg/dL),
IgA (679 mg/dL), and IgM (175 mg/dL) were ele-
vated. The titer for antinuclear antibodies was 1:40
(fine speckled type) while the serum complement (C3,
174 mg/dL; C4, 32.1 mg/dL) and double-stranded
DNA antibody level (21.6 WHO units/mL) were
both within normal limits. Flow cytometry values for
the lymphocyte subpopulation were as follows: CD3,
52% (normal range, 52–78%); CD4/CD8 ratio, 0.97
(normal range, 0.9–3.4); CD19, 9% (normal range,
8–24%); and CD56, 35% (normal range, 6–27%). The
patient’s HLAs were HLA-A*1001, HLA-B*1301,
4601 and HLA-Cw*0102,0304.
The diagnosis of Behçet’s disease was made on the
basis of recurrent genital ulcers, oral aphthosis, and acne-
like skin lesions. Treatment with colchicine 0.15 mg
twice daily was administrated initially, but the fever
persisted and there was no ulcer healing. The fever
subsided 2 days after administration of prednisolone
10 mg twice daily and scar formation over the oral
ulcers developed in the following days. The patient is
currently receiving prednisolone 10 mg daily and the
dosage will be increased if the ulcers recur. The ESR
was approximately 20–50 mm/hr, and there were no
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Figure 1. Skin lesion in incontinentia pigmenti. A typical linear
pattern of hyperpigmented lesions of incontinentia pigmenti on
the forearm was observed.
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Figure 2. Pedigree of the NEMO gene mutation family. An X-linked
dominant hereditary pattern is shown. Cases 1, 2 and 5 were
females who presented with incontinentia pigmenti. Both the
patient and her mother (5, 1) had Behçet’s disease. Cases 3 and
6, who were males from IP mothers, were stillborn (intrauterine
fetal death). Case 4 suffered from an unknown immunodeficiency
presenting with recurrent infection and received multiple courses
of intravenous immunoglobulin. He died due to sepsis before the
age of 1 month. Case 7 suffered from recurrent bacteremia and
hypogammaglobulinemia. He is currently receiving monthly intra-
venous immunoglobulin injections and prophylactic antibiotics.
fever episodes or genital ulcers after corticosteroid
administration.
Discussion
We have described the concurrence of IP and Behçet’s
disease in 2 members of a family. To the best of our
knowledge, this phenomenon has never been reported
in the literature. Interestingly, Behçet’s disease in both
cases had pediatric onset, which accounts for only 5.4%
of all Behçet’s disease cases.7
The patient’s mother was a sporadic IP patient and,
unfortunately, a genetic predisposition for this disease
appears to have been passed on to her daughters.
Males from IP mothers in this family were miscarried
or presented with immunodeficiency. IP results from
mutations in the NEMO gene; however, only males
who carry less deleterious mutations can survive.8
There is accumulating evidence that IP might be
accompanied by functional and/or structural abnor-
malities of the immune system. Defects in leukocyte
chemotaxis, lymphocyte defects, and defective immune
tolerance have been reported in association with IP.9
The underlying cause of Behçet’s disease is unknown.
There are many reports about the involvement of the
immune system in Behçet’s disease, including leuko-
cytosis, elevated CRP, ESR and high levels of IgG,
IgA and IgM.3 In addition, there is an increase in 
T-cell subsets including CD8 and CD56 in Behçet’s
disease.10,11 HLA-B*51 is a strong risk factor and 
is associated with excessive action of neutrophils in
Behçet’s disease.12 The expression of HLA-B*51 and
HLA-A*2 is high in familial Behçet’s disease.13
The immunological status of our patient was eval-
uated. Scar formation over the bacille Calmette-Guérin
site indicated intact T-cell function. A pathergy test
was negative in our case, although it is common in
some populations.14 The laboratory findings includ-
ing neutrophilia, hypergammaglobulinemia, elevated
CRP, ESR and an increase in the proportion of CD8+,
and CD56+ T-cells were consistent with previous
immunological phenotypes of Behçet’s disease. Both
HLA-B*51 and HLA-A*2, which are reported to be
associated with familial Behçet’s disease, were negative
in our patient.
The diagnosis of Behçet’s disease is based on clini-
cal manifestations, and the criteria of the International
Study Group for Behçet’s Disease are most widely
used.15 Various sets of diagnostic criteria are currently in
use, but none of them have been validated. According
to the International Study Group criteria, the diagnosis
of Behçet’s disease is made on the basis of recurrent
oral ulcers plus 2 of the following clinical manifesta-
tions: recurrent genital ulcers, eye lesions, skin lesions,
and a positive pathergy test. If only 1 of the criterion
is present along with oral ulcerations, the term “incom-
plete Behçet’s disease” is applied. Diagnosis of pedi-
atric Behçet’s disease is even more difficult because
some manifestations, such as acne-like skin lesions,
may be present only after adolescence. A large review
of pediatric Behçet’s disease showed that only 25%
were the complete type, whereas 75% were the incom-
plete type.16 It appears that the pathergy test is not
suitable for the diagnosis of pediatric Behçet’s disease
because only 17.5% of pediatric Behçet’s disease cases
have a positive pathergy test.16 Uveitis is uncommon in
pediatric Behçet’s disease. The mean age at the time of
uveitis onset is 30.8 years with a male predominence.17
However, once uveitis has occurred in Behçet’s dis-
ease, the final visual acuity is worse than that in other
forms of uveitis.18
The pathogenesis of IP results from NEMO gene
mutations, but there is no evidence of the involve-
ment of the IκB kinase pathway in Behçet’s disease.
There are only 2 case reports of Behçet’s disease in 
IP patients. There does not appear to be any relation-
ship between the pathogenesis of these 2 diseases
based on previous data. However, Ammann et al
reported an association of IP in 2 of 6 children with
Behçet’s disease.19 In the present report, the patient
and her mother were both diagnosed with concurrence
of IP and Behçet’s disease. Genetic anticipation may
play a role in pediatric or familial Behçet’s disease.20
Impaired neutrophil chemotaxis has been proposed 
as a common pathogenesis in the 2 diseases.4 Since
there are few data regarding a common pathogenesis
in these 2 diseases, we investigated possible associations
between IP and Behçet’s disease. Further studies on a
possible pathogenetic link between Behçet’s disease
and IP are now required to clarify their association.
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